Fibroblast Signaling and Angiogenesis in NSCLC: Key Mechanisms
Researchers at the University of Barcelona have identified that tumor-associated fibroblasts (TAFs) act as primary regulators of blood vessel formation in non-small cell lung cancer (NSCLC), explaining why lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) respond differently to anti-angiogenic therapies. Published in Cell Death & Disease, the study shows that fibroblast-driven differences in oxygen … Read more